Tuesday, December 02, 2008
 
 
  Home arrow Abstinence arrow Chemical Methods arrow Abortion RU-486 to Be Used As Birth Control Pill to Lessen Chance of Breast Cancer (2006)
Main Menu
Home
About Us
Current Headlines
Abortion
Abstinence
Birth Control
End of Life / Euthanasia
Medical Research
Medical Students
Population
Position Statements
Pregnancy/Development
STDs
Stem Cells & Cloning
Contact Us
Web Links
Site Index
Resources
Related Items
Translator
Quotes to Note

It's not the FUNDS that are Lacking for Embryonic Stem Cell Research.
It's the Results.

Successful human trials/treatments using Embryonic Stem Cells: 0
Successful human trials/treatments/cures using Adult Stem Cells: 72
 
FDA approved human trials using embryonic stem cells -- 0
FDA approved clinical trials using adult stem cells -- 1,181
 
Embryonic stem cells have been used in ANIMAL trials for 25 years.
After 25 years, and many thousands of dead mice and rats, ESCs have not been shown safe enough for trials in humans, mainly because of their propensity to form tumors (grow uncontrollably), and because of their rejection problems.


[Life Insight, June-July 2006]

 
Abortion RU-486 to Be Used As Birth Control Pill to Lessen Chance of Breast Cancer (2006) PDF Print E-mail

Pharmaceutical companies and the medical community have suddenly acknowledged a link between the birth control pill and breast cancer.

Numerous studies showing a clear link between the use of birth control and the development of breast cancer have been largely ignored or denied in the past by drug companies and the medical community.

Now, an alternative drug that would supposedly reduce the risk of breast cancer is being promoted. Several groups of scientists and pharmaceutical companies are working to produce a contracepting pill that would not trigger cancer growth [Telegraph, 26March2006].

The drug under study is a hormone-inhibitor, better known as the dangerous and controversial drug used to induce abortions, RU-486.

RU-486 has been linked to multiple deaths of women in Europe and the United States. The recent deaths of two more women in the US led the Food and Drug Administration to issue a Public Health Advisory, alerting consumers to the potential danger of the drug.

The abortifacient drug causes severe bleeding, in some cases leading to haemorrhage.

Over 600 reports of dangerous complications related to the drug’s use have been reported in the US alone since it was approved. Despite the volume of reports, the FDA has refused to pull the drug from the market.

Scientists are praising RU-486 as the next new contraceptive that will lower the risk of breast cancer for women by stopping their menstrual cycle altogether.

“We are looking at an entirely new type of pill that abolishes periods. It will have enormous health benefits,” said Prof David Baird, emeritus professor of reproductive endocrinology at the Edinburgh University, who has led early human trials of the drug.

Prof Baird’s team has tested the drug on women in Nigeria, South Africa and Hong Kong.
 
Two More Women Die After Medical Abortion with Abortion Pill RU-486, FDA Warns
http://www.lifesite.net/ldn/2006/mar/06031702.html

BIRTH CONTROL PILL / BREAST CANCER STUDY ANOTHER VICTIM OF BIASED REPORTING
http://www.lifesite.net/ldn/2002/jul/02070207.html
Canadian MP says Cancer Society Withholding Pill/Cancer Link
http://www.lifesite.net/ldn/2006/mar/06031707.html [26March2006, Lifesitenews.com, Schultz, UK]

 
Next >


Go to top of page  Home | About Us | Current Headlines | Abortion | Abstinence | Birth Control | End of Life / Euthanasia | Medical Research | Medical Students | Population | Position Statements | Pregnancy/Development | STDs | Stem Cells & Cloning | Contact Us | Web Links | Site Index | Resources |
 
PhysiciansForLife.org Copyright (C) 2004-2008 All Rights Reserved